Connect your AI

AdaptHealth AHCO Diabetes Health — Goodwill from acquisitions (note 3)

Other segment segments

Wellness at Home

$11.66M—

Respiratory Health

$10.65M—

Sleep Health

$3.63M—

Similar metrics at other companies

RDNTDigital Health — Goodwill from acquisitions

$19.15M—

RDNTDigital Health segment — Goodwill from acquisitions

$170.85M—

LHDiagnostics — Goodwill acquired, excluding measurement period adjustments

$146.6M—

LHDiagnostics — Goodwill

$5.61B—

HURNHealthcare — Goodwill recorded in connection with business acquisitions(1)

$0—

HURNHealthcare — Goodwill recorded in connection with business acquisition(1)

$53.8M+271%

Other financials

Income statement

Revenue$819.8M+5.4%

Gross profit$111.5M-7.4%

Operating income$5.5M-76.3%

Net income-$16.0M-123%

EPS (diluted)-$0.12-140%

Balance sheet

Cash & equivalents$48.0M-10.6%

Total debt$2.0B-4.9%

Total equity$1.5B-3.9%

Total assets$4.4B-0.3%

Cash flow

Operating cash flow$93.7M-1.9%

CapEx$121.2M+26.8%

Free cash flow-$27.5M-47,297%

Valuation

Market cap$1.36B+20.5%

Enterprise value$3.32B+4.3%

P/S0.4×+0.1×

Profitability

Gross margin18.3%-1.6pp

Operating margin8%+6.9pp

Net margin-2.4%-5.1pp

FCF margin5.8%-2.6pp

Returns & leverage

Return on equity-5.2%-10.8pp

Debt / equity1.3×0.0×

Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's diabetes health — goodwill from acquisitions (note 3).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AdaptHealth's diabetes health — goodwill from acquisitions (note 3)?: AdaptHealth (AHCO) reported diabetes health — goodwill from acquisitions (note 3) of $0 in Q1 2026.
What does diabetes health — goodwill from acquisitions (note 3) mean?: Specifically tracks the initial goodwill recognized on the balance sheet resulting from business combinations within the diabetes health segment. This metric highlights the historical capital deployed for inorganic growth and expansion strategies.